Company Overview
Aché is a leading Brazilian pharmaceutical group, ranked #1 in the Rx market. ACH24 (vitiligo) and ACH36 (anxiety) are the company’s most promising NCE’s in clinical development. Aché also offers a variety of incremental innovation products, based on differentiated technology platforms.